Scarica l'app Stockscreener
42.03
18.33%
6.51
Dopo l'orario di chiusura:
42.90
0.87
+2.07%
Precedente Chiudi:
$35.52
Aprire:
$43.37
Volume 24 ore:
2.59M
Relative Volume:
3.72
Capitalizzazione di mercato:
$1.47B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+14.00%
1M Prestazione:
+162.20%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$39.60
$46.45
Intervallo di 1 settimana:
$34.72
$46.45
Portata 52W:
$14.72
$46.45
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Nome
First Tracks Biotherapeutics Inc
Settore
Industria
Telefono
212-373-3000
Indirizzo
10770 WATERIDGE CIRCLE, SAN DIEGO
Compare TRAX vs VRTX, REGN, ARGX, RVMD, ALNY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
42.03 | 1.24B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-24 | Iniziato | Leerink Partners | Outperform |
| 2026-04-24 | Iniziato | Wedbush | Outperform |
| 2026-04-23 | Iniziato | JP Morgan | Overweight |
| 2026-04-22 | Iniziato | Barclays | Overweight |
| 2026-04-21 | Iniziato | UBS | Buy |
First Tracks Biotherapeutics Inc Borsa (TRAX) Ultime notizie
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential - TipRanks
After Forte acquisition, H.C. Wainwright says First Tracks could be target - TipRanks
TRAX Stock Volatile As Traders Focus On Cash And Momentum - StocksToTrade
Wedbush Adjusts First Tracks Biotherapeutics Price Target to $60 From $30, Maintains Outperform Rating - marketscreener.com
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
These stocks that are showing activity before the opening bell on Monday. - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anaptysbio, Inc Net Worth (2026) - GuruFocus
Which stocks are moving before the opening bell on Thursday? - ChartMill
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
First Tracks Biotherapeutics Ord Shs (TRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $54 - Moomoo
TRAX Stock Hits All-Time High — What's Driving The Super Rally? - Stocktwits
First Tracks Biotherapeutics (TRAX) Stock Forum and Discussion - Moomoo
First Tracks Biotherapeutics Inc. (TRAX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
First Tracks Biotherapeutics (TRAX) News Flow - Moomoo
Wells Fargo Reaffirms Their Buy Rating on First Tracks Biotherapeutics Inc (TRAX) - The Globe and Mail
XPEV Stock Rises 1.5% As CEO Takes First Robotaxi Ride In Guangzhou - Stocktwits
Meta, Moderna among market cap stock movers on Friday By Investing.com - Investing.com Australia
TRAX Stock Surges As Traders Pile Into Biotech Momentum - timothysykes.com
Lithium Americas Corp. (LAC) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Meta, Moderna among market cap stock movers on Friday - Investing.com UK
First Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright - TipRanks
Aehr Test Systems, Lam Research, Applied Materials And Other Big Stocks Moving Higher On Thursday - Sahm
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart - mexc.co
J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Biotech Stocks At 52-Week Highs: TRAX, BBIO, MNPR, TXG, MPLT - RTTNews
H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $44 - Moomoo
Wells Fargo Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Barclays Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Market Movers | Winners: FBRX, TRAX, CIRC | Losers: BYRN, RXT, AEON - Trefis
TRAX Stock Explodes Higher As Traders Pile Into Momentum - timothysykes.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Forte, First Tracks soar on CD122 success in vitiligo; celiac next - BioWorld News
H.C. Wainwright reiterates First Tracks stock Buy rating at $30 By Investing.com - Investing.com Canada
TRAX Reiterated by First Tracks -- Price Target Maintained at $3 - GuruFocus
Is AnaptysBio’s (ANAB) Index Exit and Office Sublease Quietly Reframing Its Strategic Focus? - simplywall.st
First Tracks Biotherapeutics, Inc.(NasdaqGS:TRAX) added to Russell Microcap Value Benchmark Index - marketscreener.com
First Tracks Biotherapeutics, Inc.(NasdaqGS:TRAX) added to Russell 2000 Value Benchmark - marketscreener.com
First Tracks Biotherapeutics, Inc.(NasdaqGS:TRAX) added to Russell 2500 Value Benchmark - marketscreener.com
TRAX Forecast — Price Target — Prediction for 2027 - TradingView
The Nasdaq Biotechnology Index closed up more than 1.52%. Among its constituents, Absci surged 35.96%, Silence Therapeutics rose 26.00%, and Aardvark Therapeutics, Definium Therapeutics, Black Diamond, Personalis, and Adaptive Biotechnologies gai - Bitget
AnaptysBio Subleases San Diego Facility to First Tracks - The Globe and Mail
First Tracks Biotherapeutics (NASDAQ: TRAX) subleases 45,057 sq ft in San Diego - Stock Titan
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
First Tracks Biotherapeutics Inc Azioni (TRAX) Dati Finanziari
Non sono disponibili dati finanziari per First Tracks Biotherapeutics Inc (TRAX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):